SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Cash flow Shanghai Shyndec Pharmaceutical Co., Ltd.

Equities

600420

CNE000001JG2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-04-13			5-day change	1st Jan Change
9.830 ^CNY	-5.48%		-6.74%	-2.67%

04-13	Shanghai Shyndec Pharmaceutical Expects Up to 65% Decline in Q1 Attributable Profit; Shares Slide 6%	MT
04-07	Shanghai Shyndec Pharmaceutical Gets China Supplementary Drug Approval for Expectorant	MT

99345d17a6c1c828235c89d0e7636a.PV0XJ1vRVxUu16qiXedkelkpHv3CVnm2eK3-mixl9uM.f3BubHaDFFZXsJnqAowuDWhTQcuABRzsAMzIqxkJvI12NX9VAuc8Z3_n3Q

Published financial data: SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	13.76B	12.81B	11.79B	10.77B	9.22B
Other Revenues, Total	189M	150M	283M	168M	145M
Total Revenues	13.94B	12.96B	12.07B	10.94B	9.36B
Cost of Goods Sold, Total	7.91B	8.09B	7.54B	6.82B	6.44B
Gross Profit	6.04B	4.87B	4.53B	4.12B	2.93B
Selling General & Admin Expenses, Total	4.22B	3.41B	2.91B	1.92B	1.28B
Provision for Bad Debts	24.87M	-17.59M	-18.05M	-2.36M	15.67M
R&D Expenses	585M	517M	562M	566M	438M
Other Operating Expenses	128M	113M	115M	78.88M	78.12M
Other Operating Expenses, Total	4.96B	4.03B	3.57B	2.56B	1.81B
Operating Income	1.08B	841M	967M	1.55B	1.11B
Interest Expense, Total	-110M	-107M	-57.88M	-36.89M	-4.39M
Interest And Investment Income	48.84M	61.69M	136M	151M	177M
Net Interest Expenses	-61.62M	-45.62M	78.59M	114M	173M
Currency Exchange Gains (Loss)	-32.65M	98.32M	28.44M	40.61M	2.29M
Other Non Operating Income (Expenses)	-5.75M	-4.23M	-4.09M	-2.01M	-2.31M
EBT, Excl. Unusual Items	978M	890M	1.07B	1.71B	1.29B
Impairment of Goodwill	-132M	-	-	-	-
Gain (Loss) On Sale Of Investments	-24.04M	-	-	-	-
Gain (Loss) On Sale Of Assets	203K	-1.1M	-31.85M	-31.31M	-2.65M
Asset Writedown	-10.81M	-4.93M	-13.66M	-28.26M	-32.79M
Legal Settlements	-	-	-	-	-
Other Unusual Items	107M	100M	71.77M	27.33M	76.19M
EBT, Incl. Unusual Items	918M	984M	1.1B	1.67B	1.33B
Income Tax Expense	97.06M	117M	132M	341M	185M
Earnings From Continuing Operations	821M	867M	965M	1.33B	1.14B
Net Income to Company	821M	867M	965M	1.33B	1.14B
Minority Interest	-253M	-240M	-273M	-248M	-201M
Net Income - (IS)	568M	628M	692M	1.08B	942M
Net Income to Common Incl Extra Items	568M	628M	692M	1.08B	942M
Net Income to Common Excl. Extra Items	568M	628M	692M	1.08B	942M
Per Share Items
Net EPS - Basic	0.55	0.61	0.54	0.81	0.7
Basic EPS - Continuing Operations	0.55	0.61	0.54	0.81	0.7
Basic Weighted Average Shares Outstanding	1.03B	1.03B	1.27B	1.34B	1.34B
Net EPS - Diluted	0.48	0.54	0.54	0.81	0.7
Diluted EPS - Continuing Operations	0.48	0.54	0.54	0.81	0.7
Diluted Weighted Average Shares Outstanding	1.18B	1.16B	1.27B	1.34B	1.34B
Normalized Basic EPS	0.35	0.31	0.31	0.61	0.45
Normalized Diluted EPS	0.3	0.27	0.31	0.61	0.45
Dividend Per Share	0.1	0.1	0.1	0.3	0.3
Payout Ratio	37.39	29.42	27.37	27.75	45.44
Supplemental Items
EBITDA	1.85B	1.67B	1.77B	2.3B	1.81B
EBITA	1.11B	874M	999M	1.59B	1.17B
EBIT	1.08B	841M	967M	1.55B	1.11B
EBITDAR	1.91B	1.69B	1.8B	2.33B	1.83B
Total Revenues (As Reported)	13.94B	12.96B	12.07B	10.94B	9.36B
Effective Tax Rate - (Ratio)	10.57	11.85	12.03	20.38	13.97
Total Current Taxes	125M	174M	143M	242M	206M
Total Deferred Taxes	-27.54M	-56.98M	-11.45M	98.61M	-20.96M
Normalized Net Income	358M	316M	396M	817M	604M
Interest Capitalized	38.56M	29.27M	-	-	-
Interest on Long-Term Debt	67.73M	-	-	2.97M	2.33M
Non-Cash Pension Expense	421K	-32.79K	224K	15.4K	-
Supplemental Operating Expense Items
Advertising Expense	7.1M	3.29M	4.64M	6.18M	4.69M
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	3.48B	2.74B	2.15B	1.15B	530M
General and Administrative Expenses	722M	652M	744M	766M	750M
Research And Development Expense From Footnotes	603M	539M	586M	598M	487M
Net Rental Expense, Total	56.59M	28.89M	29.52M	22.3M	17.56M
Imputed Operating Lease Interest Expense	16.89M	8.32M	6.01M	5.77M	1.04M
Imputed Operating Lease Depreciation	39.69M	20.57M	23.51M	16.53M	16.52M
Maintenance & Repair Expenses, Total	18.5M	19.71M	25M	34.46M	18.05M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.28B	6.15B	5.97B	6.21B	4.01B
Short Term Investments	-	-	-	1.43B	3.06B
Total Cash And Short Term Investments	4.28B	6.15B	5.97B	7.64B	7.06B
Accounts Receivable, Total	3.05B	2.66B	2.05B	1.36B	1.17B
Other Receivables	96.91M	92.85M	84.07M	85.55M	81.55M
Notes Receivable	-	-	-	-	-
Total Receivables	3.14B	2.75B	2.13B	1.45B	1.25B
Inventory	3.07B	2.44B	2.28B	2.21B	1.75B
Prepaid Expenses	40.21M	47.69M	61.63M	70.29M	71.07M
Other Current Assets, Total	345M	300M	207M	315M	1.12B
Total Current Assets	10.89B	11.68B	10.66B	11.68B	11.25B
Gross Property Plant And Equipment	12.52B	12.88B	13.05B	13.19B	13.2B
Accumulated Depreciation	-6.01B	-6.63B	-7.17B	-7.64B	-7.86B
Net Property Plant And Equipment	6.51B	6.25B	5.88B	5.55B	5.34B
Long-term Investments	371M	376M	1.43B	1.32B	1.23B
Goodwill	160M	160M	160M	160M	160M
Other Intangibles, Total	549M	517M	511M	591M	760M
Deferred Tax Assets Long-Term	189M	239M	153M	103M	116M
Deferred Charges Long-Term	145M	228M	332M	334M	227M
Other Long-Term Assets, Total	259M	179M	224M	217M	136M
Total Assets	19.07B	19.63B	19.35B	19.96B	19.23B
Liabilities
Accounts Payable, Total	1.54B	1.25B	1.37B	1.1B	1.65B
Accrued Expenses, Total	480M	1.67B	1.59B	1.42B	936M
Short-term Borrowings	2.01B	321M	45.05M	50.05M	-
Current Portion of Long-Term Debt	540M	48.37M	-	1.03B	-
Current Portion of Leases	40.13M	9.86M	10.6M	8.86M	8.85M
Current Income Taxes Payable	30.86M	37.94M	29.95M	72.51M	44.25M
Unearned Revenue Current, Total	1.4B	344M	245M	193M	93.81M
Other Current Liabilities	794M	510M	481M	465M	404M
Total Current Liabilities	6.84B	4.2B	3.78B	4.34B	3.13B
Long-Term Debt	1.55B	2.96B	1.03B	-	-
Long-Term Leases	43M	68.57M	57.97M	47.94M	33.75M
Unearned Revenue Non Current	140M	138M	123M	114M	83.49M
Pension & Other Post Retirement Benefits	842K	571K	518K	364K	11.41M
Deferred Tax Liability Non Current	126M	120M	22.15M	70.77M	62.5M
Other Non Current Liabilities	-	-	-	56.96M	56.96M
Total Liabilities	8.7B	7.48B	5.01B	4.63B	3.38B
Common Stock, Total	1.03B	1.17B	1.34B	1.34B	1.34B
Additional Paid In Capital	2.55B	3.59B	5.2B	5.2B	5.21B
Retained Earnings	4.76B	5.29B	5.84B	6.66B	7.23B
Comprehensive Income and Other	259M	259M	-1.09M	-911K	-1.11M
Total Common Equity	8.59B	10.31B	12.39B	13.2B	13.78B
Minority Interest	1.78B	1.85B	1.95B	2.12B	2.07B
Total Equity	10.37B	12.15B	14.34B	15.32B	15.84B
Total Liabilities And Equity	19.07B	19.63B	19.35B	19.96B	19.23B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.03B	1.17B	1.34B	1.34B	1.34B
ECS Total Common Shares Outstanding	1.03B	1.17B	1.34B	1.34B	1.34B
Book Value / Share	8.37	8.57	9.24	9.85	10.27
Tangible Book Value	7.88B	9.63B	11.72B	12.45B	12.86B
Tangible Book Value Per Share	7.68	7.99	8.74	9.28	9.59
Total Debt	4.18B	3.4B	1.14B	1.14B	42.6M
Net Debt	-99.84M	-2.74B	-4.83B	-6.51B	-7.02B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.07M	807K	782K	472K	-
Debt Equivalent Oper. Leases	453M	231M	236M	178M	141M
Minority Interest, Total (Incl. Fin. Div)	1.78B	1.85B	1.95B	2.12B	2.07B
Equity Method Investments, Total	145M	150M	156M	169M	194M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.06B	864M	708M	632M	516M
Inventories - Work In Process, Total	544M	556M	481M	404M	400M
Inventories - Finished Goods, Total	1.45B	1.02B	1.08B	1.19B	844M
Inventories - Others	86.38M	81.24M	85.04M	62.46M	47.31M
Buildings, Total	3.87B	3.94B	4.47B	4.49B	4.38B
Machinery, Total	7.92B	8.18B	8.37B	8.45B	8.53B
Full Time Employees	11.94K	11.49K	11.61K	11.47K	-
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	101M	86.54M	68.16M	59.48M	63.53M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	568M	628M	692M	1.08B	942M
Depreciation & Amortization - CF	786M	804M	782M	728M	650M
Amortization of Goodwill and Intangible Assets - (CF)	29.31M	32.4M	31.32M	38.25M	60.09M
Depreciation & Amortization, Total	815M	837M	813M	766M	710M
Amortization of Deferred Charges, Total - (CF)	15.83M	11.98M	12.33M	12.07M	13.43M
(Gain) Loss From Sale Of Asset	-203K	1.1M	31.85M	31.31M	2.65M
(Gain) Loss on Sale of Investments - (CF)	24.04M	-2.34M	-27.45M	-64.11M	-134M
Asset Writedown & Restructuring Costs	136M	3.43M	13.13M	28.26M	32.79M
Provision and Write-off of Bad Debts	24.87M	-17.59M	-18.05M	-2.36M	15.67M
Other Operating Activities, Total	406M	394M	399M	427M	297M
Change In Accounts Receivable	-921M	463M	485M	733M	187M
Change In Inventories	195M	625M	163M	60.54M	486M
Change In Accounts Payable	444M	-30.39M	-833M	-919M	-833M
Change In Deferred Taxes	-27.54M	-56.98M	-11.45M	98.61M	-20.96M
Cash from Operations	1.68B	2.86B	1.72B	2.26B	1.7B
Capital Expenditure	-521M	-307M	-357M	-220M	-264M
Sale of Property, Plant, and Equipment	3.72M	5M	10.96M	21.95M	6.15M
Divestitures	-	-	-	-	103M
Investment in Marketable and Equity Securities, Total	1.14M	-	2.01M	3M	3.03M
Other Investing Activities, Total	8.31M	-	-1.02B	-661M	-2.24B
Cash from Investing	-508M	-302M	-1.36B	-856M	-2.39B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	3.69B	2.35B	45M	50M	-
Total Debt Issued	3.69B	2.35B	45M	50M	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-3.4B	-3.19B	-774M	-61.44M	-1.06B
Total Debt Repaid	-3.4B	-3.19B	-774M	-61.44M	-1.06B
Issuance of Common Stock	-	1.19B	-	-	-
Common Dividends Paid	-212M	-185M	-189M	-301M	-428M
Common & Preferred Stock Dividends Paid	-212M	-185M	-189M	-301M	-428M
Other Financing Activities, Total	-733M	-594M	-175M	-103M	-154M
Cash from Financing	-662M	-435M	-1.09B	-415M	-1.64B
Foreign Exchange Rate Adjustments	-40.08M	94.24M	32.07M	29.63M	15.34M
Net Change in Cash	469M	2.21B	-704M	1.01B	-2.32B
Supplemental Items
Cash Income Tax Paid (Refund)	696M	618M	752M	693M	608M
Levered Free Cash Flow	622M	1.63B	1.8B	1.68B	874M
Unlevered Free Cash Flow	691M	1.7B	1.83B	1.7B	876M
Change In Net Working Capital	292M	-634M	-760M	-173M	279M
Net Debt Issued / Repaid	283M	-845M	-729M	-11.44M	-1.06B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.61	2.72	3.1	4.94	3.55
Return on Total Capital	4.78	3.49	3.9	6.08	4.3
Return On Equity %	8.13	7.7	7.28	8.98	7.33
Return on Common Equity	6.8	6.64	6.1	8.47	6.98
Margin Analysis
Gross Profit Margin %	43.28	37.57	37.55	37.63	31.24
SG&A Margin	30.26	26.35	24.07	17.56	13.67
EBITDA Margin %	13.28	12.85	14.63	21.07	19.36
EBITA Margin %	7.94	6.74	8.27	14.54	12.54
EBIT Margin %	7.73	6.49	8.01	14.19	11.9
Income From Continuing Operations Margin %	5.89	6.69	7.99	12.18	12.2
Net Income Margin %	4.08	4.84	5.73	9.91	10.06
Net Avail. For Common Margin %	4.08	4.84	5.73	9.91	10.06
Normalized Net Income Margin	2.57	2.44	3.28	7.47	6.45
Levered Free Cash Flow Margin	4.46	12.61	14.88	15.35	9.33
Unlevered Free Cash Flow Margin	4.95	13.12	15.18	15.56	9.36
Asset Turnover
Asset Turnover	0.75	0.67	0.62	0.56	0.48
Fixed Assets Turnover	2.16	2.03	1.99	1.91	1.72
Receivables Turnover (Average Receivables)	4.87	4.49	5.01	6.31	7.29
Inventory Turnover (Average Inventory)	2.49	2.94	3.19	3.04	3.25
Short Term Liquidity
Current Ratio	1.59	2.78	2.82	2.69	3.59
Quick Ratio	1.09	2.12	2.15	2.09	2.65
Operating Cash Flow to Current Liabilities	0.25	0.68	0.46	0.52	0.54
Days Sales Outstanding (Average Receivables)	74.96	81.25	72.87	57.97	50.04
Days Outstanding Inventory (Average Inventory)	146.61	124.33	114.28	120.43	112.21
Average Days Payable Outstanding	86.43	68.31	64.89	67.15	83.97
Cash Conversion Cycle (Average Days)	135.13	137.28	122.27	111.25	78.29
Long Term Solvency
Total Debt/Equity	40.35	28	7.98	7.43	0.27
Total Debt / Total Capital	28.75	21.88	7.39	6.91	0.27
LT Debt/Equity	15.33	24.88	7.59	0.31	0.21
Long-Term Debt / Total Capital	10.93	19.44	7.03	0.29	0.21
Total Liabilities / Total Assets	45.62	38.09	25.91	23.22	17.59
EBIT / Interest Expense	9.76	7.84	16.71	42.09	253.96
EBITDA / Interest Expense	17.14	15.64	30.76	62.86	415.88
(EBITDA - Capex) / Interest Expense	12.42	12.77	24.58	56.9	355.72
Total Debt / EBITDA	2.21	2.03	0.64	0.49	0.02
Net Debt / EBITDA	-0.05	-1.64	-2.71	-2.81	-3.85
Total Debt / (EBITDA - Capex)	3.05	2.48	0.8	0.54	0.03
Net Debt / (EBITDA - Capex)	-0.07	-2	-3.39	-3.1	-4.5
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.06	-7.07	-6.86	-9.38	-14.4
Gross Profit, 1 Yr. Growth %	4.23	-19.34	-6.9	-9.19	-28.92
EBITDA, 1 Yr. Growth %	1.64	-10.3	5.66	27.87	-22.04
EBITA, 1 Yr. Growth %	-1.63	-21.48	13.54	55.85	-26.49
EBIT, 1 Yr. Growth %	-1.54	-21.96	14.99	57.87	-28.26
Earnings From Cont. Operations, 1 Yr. Growth %	-8.77	5.64	11.2	38.1	-14.26
Net Income, 1 Yr. Growth %	-12.41	10.47	10.21	56.62	-13.11
Normalized Net Income, 1 Yr. Growth %	7.67	-11.72	25.23	101.2	-26.14
Diluted EPS Before Extra, 1 Yr. Growth %	-12.29	12.52	0.07	48.72	-13.11
Accounts Receivable, 1 Yr. Growth %	17.11	-12.86	-22.77	-33.64	-14.27
Inventory, 1 Yr. Growth %	-6.36	-20.59	-6.53	-3.14	-20.8
Net Property, Plant and Equip., 1 Yr. Growth %	1.59	-4.06	-5.79	-5.68	-3.76
Total Assets, 1 Yr. Growth %	4.49	2.94	-1.42	3.12	-3.65
Tangible Book Value, 1 Yr. Growth %	7.78	22.13	21.69	6.28	3.26
Common Equity, 1 Yr. Growth %	5.68	19.93	20.21	6.58	4.35
Cash From Operations, 1 Yr. Growth %	7.66	70.01	-39.76	31.13	-24.73
Capital Expenditures, 1 Yr. Growth %	37.96	-41.04	16.18	-38.47	20.04
Levered Free Cash Flow, 1 Yr. Growth %	-744.08	162.68	9.96	-7.06	-47.96
Unlevered Free Cash Flow, 1 Yr. Growth %	-3.67K	146.14	7.75	-7.63	-48.5
Dividend Per Share, 1 Yr. Growth %	0	0	0	200	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.92	1.59	-6.97	-8.13	-11.92
Gross Profit, 2 Yr. CAGR %	0.63	-8.31	-13.35	-8.05	-19.66
EBITDA, 2 Yr. CAGR %	-0.25	-4.38	-2.47	17.43	0.28
EBITA, 2 Yr. CAGR %	-3.03	-11.9	-5.26	34.48	7.24
EBIT, 2 Yr. CAGR %	-2.68	-12.35	-5.27	35.85	6.42
Earnings From Cont. Operations, 2 Yr. CAGR %	-5.96	-1.83	8.38	23.92	8.81
Net Income, 2 Yr. CAGR %	-6.95	-1.63	10.34	31.38	16.66
Normalized Net Income, 2 Yr. CAGR %	-0.27	-2.51	5.14	60.73	21.91
Diluted EPS Before Extra, 2 Yr. CAGR %	-8	-0.66	6.11	22	13.68
Accounts Receivable, 2 Yr. CAGR %	31.45	1.02	-17.97	-28.41	-24.57
Inventory, 2 Yr. CAGR %	15.12	-13.77	-13.85	-4.85	-12.41
Net Property, Plant and Equip., 2 Yr. CAGR %	2.08	-1.28	-4.93	-5.74	-4.73
Total Assets, 2 Yr. CAGR %	3.98	3.71	0.74	0.82	-0.32
Tangible Book Value, 2 Yr. CAGR %	8.34	14.73	21.91	13.72	4.76
Common Equity, 2 Yr. CAGR %	6.42	12.58	20.07	13.19	5.46
Cash From Operations, 2 Yr. CAGR %	15	35.29	1.2	-11.12	-0.65
Capital Expenditures, 2 Yr. CAGR %	13.63	-9.81	-17.23	-15.45	-14.06
Levered Free Cash Flow, 2 Yr. CAGR %	36.91	311.32	69.95	1.37	-30.45
Unlevered Free Cash Flow, 2 Yr. CAGR %	79.94	837.3	62.85	0.03	-31.03
Dividend Per Share, 2 Yr. CAGR %	0	0	0	73.21	73.21
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.2	2.04	-1.31	-7.78	-10.27
Gross Profit, 3 Yr. CAGR %	3.42	-6.52	-7.84	-11.98	-15.61
EBITDA, 3 Yr. CAGR %	2.26	-3.63	-1.03	7.47	2.74
EBITA, 3 Yr. CAGR %	2.33	-9.48	-3.91	12.65	10.1
EBIT, 3 Yr. CAGR %	2.56	-9.58	-4.05	12.93	9.81
Earnings From Cont. Operations, 3 Yr. CAGR %	-8.45	-2.24	2.34	17.5	9.6
Net Income, 3 Yr. CAGR %	-6.96	-1.47	2.17	24	14.47
Normalized Net Income, 3 Yr. CAGR %	-5.85	-4.24	5.98	31.63	24.03
Diluted EPS Before Extra, 3 Yr. CAGR %	-9.27	-1.61	-0.41	18.75	8.95
Accounts Receivable, 3 Yr. CAGR %	20.76	14.62	-7.63	-23.56	-23.98
Inventory, 3 Yr. CAGR %	9.89	1.72	-11.42	-10.42	-10.49
Net Property, Plant and Equip., 3 Yr. CAGR %	2.2	-0.01	-2.8	-5.18	-5.08
Total Assets, 3 Yr. CAGR %	5.02	3.63	1.97	1.52	-0.69
Tangible Book Value, 3 Yr. CAGR %	10.14	12.75	17.01	16.46	10.12
Common Equity, 3 Yr. CAGR %	8.08	10.74	15.07	15.4	10.17
Cash From Operations, 3 Yr. CAGR %	0.21	31	3.31	10.33	-15.91
Capital Expenditures, 3 Yr. CAGR %	9.29	-8.69	-1.87	-25.02	-4.97
Levered Free Cash Flow, 3 Yr. CAGR %	-38.55	70.12	164.97	39.24	-18.83
Unlevered Free Cash Flow, 3 Yr. CAGR %	-37.33	99.75	355.75	35.05	-19.83
Dividend Per Share, 3 Yr. CAGR %	0	0	0	44.22	44.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.85	8.76	1.29	-2.16	-5.7
Gross Profit, 5 Yr. CAGR %	13.44	6.06	-3.64	-7.14	-12.76
EBITDA, 5 Yr. CAGR %	-0.43	-2.42	0.4	4.37	-0.1
EBITA, 5 Yr. CAGR %	-2.06	-4.88	-0.68	6.2	0.84
EBIT, 5 Yr. CAGR %	-1.58	-4.66	-0.65	6.41	0.34
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.78	1.17	-2.05	7.49	4.88
Net Income, 5 Yr. CAGR %	3.57	4.01	-0.39	10.55	7.73
Normalized Net Income, 5 Yr. CAGR %	11.13	7.92	-1.6	17.8	12.65
Diluted EPS Before Extra, 5 Yr. CAGR %	2.34	3.16	-3.41	7.23	5
Accounts Receivable, 5 Yr. CAGR %	5	5.87	3.45	-5.05	-14.82
Inventory, 5 Yr. CAGR %	11.17	4.92	-0.3	-0.96	-11.82
Net Property, Plant and Equip., 5 Yr. CAGR %	-2.12	-1.52	-0.71	-2.34	-3.58
Total Assets, 5 Yr. CAGR %	4.9	5.29	3.29	2.5	1.05
Tangible Book Value, 5 Yr. CAGR %	11.38	13.44	14.7	13.14	11.94
Common Equity, 5 Yr. CAGR %	8.54	10.79	12.73	11.72	11.12
Cash From Operations, 5 Yr. CAGR %	14.9	4.29	0.61	12.18	1.71
Capital Expenditures, 5 Yr. CAGR %	16.66	12.79	-2.21	-11.46	-6.94
Levered Free Cash Flow, 5 Yr. CAGR %	-2.21	4.19	-7.69	38.3	55.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	-4.67	2.69	-8.18	51.48	114.37
Dividend Per Share, 5 Yr. CAGR %	-5.11	14.87	0	24.57	24.57